thumbnail image
  • Company
  • Pipeline
  • News & Events
  • Careers
  • Contact
  • Company
  • Pipeline
  • News & Events
  • Careers
  • Contact
    • News, Events, & Media Archive

    • Press Releases

      twoXAR Pharmaceuticals Presents Preclinical Data Demonstrating Positive Safety and Tolerability of Two Novel NASH Treatment Candidates

      November 13, 2020

      twoXAR Pharmaceuticals Presents Positive Preclinical Safety and Efficacy Data for its Novel Investigational Cancer Treatment TXR-311

       

      June 22, 2020

      Howard Rosen Joins twoXAR Pharmaceuticals' Board of Directors

      June 3, 2020

      twoXAR Pharmaceuticals Presents Preclinical Data Demonstrating Positive Safety and Tolerability of Two Novel Lupus Drug Leads

      April 21, 2020

      twoXAR Pharmaceuticals Announces Appointment of Mark Eller, Ph.D. as Senior Vice President of Research and Development and Anjali Pandey, Ph.D. as Senior Vice President of Nonclinical R&D and Chemistry

      March 3, 2020

      1ST Biotherapeutics and twoXAR Advance Three Novel Glioblastoma Treatment Candidates into In Vivo Testing in Less Than One Year

      February 25, 2020

      twoXAR Announces Appointment of Allen Poirson, Ph.D. as Senior Vice President of Biopharmaceutical Business Development

      September 17, 2019

      SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer

      April 18, 2019

      English, 한국어

      Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration

      March 18, 2019

      English, 日本語

      1ST Biotherapeutics and twoXAR Form Co-Development Collaboration to Discover and Develop Treatments for Glioblastoma

      January 3, 2019

      English, 한국어

      twoXAR Receives $225K Phase I SBIR Grant for Pancreatic Cancer Drug Discovery

      November 28, 2018

      Adynxx and twoXAR Form Collaboration to Discover and Develop Treatments for Endometriosis

      November 15, 2018

      KemPharm and twoXAR Announce Technology Collaboration to Develop
      Prodrug-Based Therapies for Multiple Indications

      October 23, 2018

      SoftBank Ventures Leads $10M Investment in AI-Driven Drug Discovery Company twoXAR

      March 19, 2018

      English, 中文, 한국어, 日本語

      twoXAR Announces Formation of Business Advisory Board

      November 27, 2017

      MIT Startup Exchange Names twoXAR to STEX25

      June 28, 2017

      twoXAR Announces Preclinical Proof-of-Concept Data on Type 2 Diabetes Candidate

      June 19, 2017

      twoXAR Appoints Brian Moriarty as CFO and Jill Jene, PhD, as SVP, Business Development

      May 15, 2017

      twoXAR to Present Data from In Vivo Studies Investigating New Rheumatoid Arthritis Drug Candidates at IMMUNOLOGY 2017

      May 3, 2017

      twoXAR Appoints Distinguished Researchers to New Scientific Advisory Board

      April 10, 2017

      twoXAR Announces Preclinical Proof-of-Concept Data on Novel Liver Cancer Candidate

      March 14, 2017

      Santen and twoXAR Announce Strategic Research Collaboration to Discover New Glaucoma Treatments

      February 23, 2017

      Study reveals drug interactions that may reduce mortality in breast cancer patients

      December 9, 2016

      twoXAR Collaborates with Researchers at Mount Sinai to Advance New Medicines for Diabetic Nephropathy

      October 4, 2016

      twoXAR Sets Sights on Liver Cancer With New Collaboration

       

      September 8, 2016

      twoXAR Completes Initial Studies of New Rheumatoid Arthritis Drug Candidates

      June 14, 2016

       

      twoXAR Enters Research Collaboration with the University of Chicago Department of Medicine to Investigate New Atherosclerosis Medicines

      May 25, 2016

      twoXAR Joins Hunt for Medicines Targeting Rare Skin Diseases

      April 28, 2016

      Andreessen Horowitz Leads $3.4M Investment in twoXAR to Accelerate Discovery of New Medicines

      November 18, 2015

      twoXAR Accelerates Digital Assault on Drug Discovery With Support From Stanford-Backed StartX Med Program

      June 24, 2015

    • Events

      Innovation in Drug Research and Development for Chronic Diseases - Part 1

      National Academies of Science, Engineering, and Medicine (Virtual)

      February 22, 2021

      twoXAR Pharmaceuticals CEO Andrew A. Radin presents in a session on new technologies enabling discovery research.

      2021 MIT ILP WuXi Virtual Symposium

      MIT ILP (Digital)

      January 27, 2021

      twoXAR Pharmaceuticals CEO Andrew Radin presents at the MIT Startup Exchange Lightning Talk.

      Biotech Showcase

      Digital

      January 11-15, 2021

      twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules.

      Using Artificial Intelligence in Drug Discovery

      CM Life Sciences (Digital)

      December 3, 2020

      twoXAR Pharmaceuticals CEO Andrew A. Radin joins a webinar hosted by CM Life Sciences to discuss harnessing AI in drug discovery.

       

      On Demand Video

      EPPIC Global Presents: Role of AI/ML in transforming and accelerating the drug discovery process

      EPPIC Global (Digital)

      October 17, 2020

      twoXAR Pharmaceuticals SVP Nonclinical R&D & Chemistry Anjali Pandey moderates a panel including twoXAR CEO Andrew Radin, along with representatives from Recursion Pharma, ATOM Consortium, and NuMedii.

      MIT ILP: Precision Medicine in Oncology

      MIT ILP (Digital)

      October 16, 2020

      twoXAR Pharmaceuticals CEO Andrew Radin presents on the company's capabilities in discovering first-in-class small molecules for oncology and more using AI.

      J&J JLabs: Level Up: Leveraging AI for Drug Discovery as a Biology Startup

      Digital
      October 1, 2020

      twoXAR Pharmaceuticals CEO Andrew Radin presents and joins the JLabs panel to discuss how biology startups can partner with AI companies.

      AI In Biopharma: Making AI/ML Tools Scalable Across the Drug Development Lifecycle to Impact Patients

      Digital

      July 14, 2020

      twoXAR Pharmaceuticals CEO Andrew Radin joins a panel to discuss AI across the drug development lifecycle

      On Demand Video

      Xconomy: Xcelerating Life Sciences San Francisco

      San Francisco, CA (DIGITAL)

      June 25, 2020

      twoXAR Pharmaceuticals CEO, Andrew A. Radin, joins a panel on "What's Next: Investment, Partnerships, and Pushing Life Sciences Forward"

      BIO International (Digital)

      Digital Meeting
      June 8-12, 2020

      twoXAR CEO Andrew Radin discusses how the company approaches drug discovery.

      DrugBank Fireside Chat

      Digital

      May 19, 2020

      twoXAR Pharmaceuticals VP Discovery, Aaron Daugherty, joins DrugBank CEO Michael Wilson in an online fireside chat on using DrugBank data sources for drug discovery.

       

      On Demand Video

      Whitepaper

      BIO-Europe Spring

      Paris, France - CHANGED TO FULL DIGITAL EVENT
      March 23-25, 2020

      twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.

      BIO CEO & Investor Conference

      New York, NY

      February 10-11, 2020

      twoXAR Pharmaceuticals CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.

      2020 MIT Japan Conference

      Tokyo, Japan

      January 24, 2020

      Join twoXAR CEO, Andrew A. Radin and Senior VP of Business Development, Allen Poirson, for an opportunity to meet with MIT-connected startups and hear about their impactful work and technology.

      AAMA Global Healthcare Conference - AI: The Next Digital Frontier for Healthcare Innovation

      San Francisco, CA

      January 13, 2020

      twoXAR CEO, Andrew A. Radin, participates in a panel discussion: Every Healthcare Professionals Dream: AI in Data, Diagnosis and Patient Care.

      China Focus@San Francisco

      San Francisco, CA

      January 12, 2020

      twoXAR CEO, Andrew A. Radin, participates in a panel discussion on AI and Digital Health.

      2019 MIT Increased Productivity in the Biopharmaceutical Industry

      Boston, MA

      December 10, 2019

      twoXAR CEO, Andrew A. Radin, participates in a startup lightning talk about twoXAR and discovering pharmaceuticals with AI.

      Ophthalmic Drugs​

       

      London, UK

      November 19-20, 2019

      twoXAR VP Discovery, Aaron Daugherty, discusses the applications of AI in Drug Discovery.

      FT Global Pharmaceutical and Biotechnology Conference​

      London, UK

      November 11-12, 2019

      twoXAR CEO, Andrew A. Radin, joins a panel discussion on 'Digital R&D: AI - The Reckoning?'

      JASIS 2019

      Makuhari Messe, Japan
      September 4-6, 2019

      twoXAR CEO, Andrew A. Radin, participates in a startup lightning talk about twoXAR and discovering pharmaceuticals with AI.

      LESI 2019 Yokohama

      Yokohama, Japan

      May 26-28, 2019

      twoXAR Co-Founder, Andrew M. Radin, discusses Recent IP and Business Trends in Advanced Drug Discovery Technology panel with Ichiro Nakatomi, S. Roy Kimura, Patrick Reid, Rob Garbaccio.

      2019 MIT Startup Showcase Japan​

      Takeda Shonan Research Center, Japan

      May 23, 2019

      twoXAR Co-Founder, Andrew M. Radin, discusses the applications of AI in Drug Discovery.

      Life Science and Innovation & AI Drug Discovery in United States - LINK-J

      Tokyo, Japan

      April 18, 2019

      twoXAR CEO, Andrew A. Radin, discusses the applications of AI in Drug Discovery.

      2018 MIT AI in Life Sciences and Healthcare Conference

      Cambridge, MA

      December 4-5, 2018

      twoXAR Co-Founder, Andrew M. Radin, discusses artificial intelligence in drug discovery.

      Ophthalmic Drugs

      London, UK

      November 26-27, 2018

      twoXAR CEO, Andrew A. Radin, discusses artificial intelligence in drug discovery and how it's impacting the discovery of novel ophthalmology therapeutics.

      AI Applications Summit | Biopharma 2018

      Boston, MA
      October 25-26, 2018

      twoXAR CEO, Andrew A. Radin, speaks on AI Applications for Identifying New Drug Candidates panel with Saurabh Saha and Ramesh Durvasula.

      AI Pharma Korea 2018

      Seoul, Korea

      October 15, 2018

      twoXAR Co-Founder, Andrew M. Radin, presents Discovering, Validating, & Launching First-In-Class Therapeutic Programs in 4 Months.

      MIT & Oxford - Healthcare Technologies of the Future

      Oxford, UK
      September 27, 2018

      twoXAR Co-Founder, Andrew M. Radin, discusses artificial intelligence in drug discovery.

      BIOplus 2018

      Seoul, Korea

      September 6-7, 2018

      twoXAR Co-Founder, Andrew M. Radin, presents Partnering in AI-Driven Drug Development.

      SoftBank World 2018

      Tokyo, Japan
      July 19-20, 2018

      twoXAR Co-Founders Andrew A. and Andrew M. share the twoXAR story and how AI is accelerating drug discovery.

      Financial Times US Healthcare & Life Sciences Summit​

      New York, NY

      May 10, 2018

      twoXAR CEO, Andrew A. Radin, speaks on AI, Robotics, Blockchain and the Digital Transformation of Healthcare and Life Sciences​ panel with Ashish Atreja, John Baldoni, Eric Perakskis, & Tom Stanis.

      MIT 2018 Startup Showcase Silicon Valley: The New Machines of Industry

      Menlo Park, CA

      March 15, 2018

      twoXAR CEO, Andrew A. Radin, speaks on The New Machines of Industry - Buy, Build or Partner: Manufacturing, IoT & AI panel with Marianne Wu, & Sangbae Kim.

      Precision Medicine World Conference - Silicon Valley

      Mountain View, CA
      January 22-24, 2018

      twoXAR CEO, Andrew A. Radin, presents How AI is Helping Find Better Medicines.

      2017 MIT Startup Showcase Japan​

      Takeda Shonan Research Center, Japan

      October 18, 2017

      twoXAR Chief Marketing Officer, Andrew M. Radin, discusses artificial intelligence in drug discovery.

      AI in Healthcare Summit 2017

      San Francisco, CA
      June 26-27, 2017

      twoXAR CEO, Andrew A. Radin, speaks on Accelerating Drug Discovery and Research with AI panel with Abraham Heifets, Vijay Pande, & Marina Sirota.

      Immunology 2017

      Washington, DC

      May 12-16, 2017

      twoXAR Senior Scientist, Aaron Daugherty, presents An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis poster.

      Stanford Drug Discovery Conference 2017 

      Palo Alto, CA

      April 24, 2017

      twoXAR Senior Scientist, Aaron Daugherty, presents An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis​ poster.

      253rd American Chemical Society - National Meeting & Exposition

      San Francisco, CA

      April 2-6, 2017

      twoXAR CEO, Andrew A. Radin, speaks on Big Data and Pharmaceutical Innovation panel with Craig Mak & Van Willis.

      TEDMED 2016

      Palm Springs, CA

      November 30 - December 2, 2016

      twoXAR CEO, Andrew A. Radin, presents What if new medications could be found in minutes instead of years?

      Cell Press's Cell Symposia: Technology. Biology. Data Science.

      Berkeley, CA

      October 9 - 11, 2016

      twoXAR CEO, Andrew A. Radin, speaks on Driving Life Science Research Through Data Science panel with Brian Naughton, Vijay Pande, & Zach Serber.

      2016 Asian Leadership Conference

      Seoul, South Korea

      May 18, 2016

      twoXAR Chief Business Officer, Andrew M. Radin, discusses starting up from universities: MIT & Stanford.

      Health 2.0 9th Annual Fall Conference 2015

      San Francisco, CA

      October 5, 2015

      twoXAR CEO, Andrew A. Radin, speaks on From the Horse's Mouth: What Happens When Digital Meets Pharma?​ panel with Anthony Costello, Chris Hogg, & Carlos Rodarte.

      2015 MIT Digital Health Conference

      Cambridge, MA

      September 16, 2015

      twoXAR CEO, Andrew A. Radin, presents at 2015 MIT Digital Health Conference.

      Sanofi Big Data Symposium: Convergence of Science, Technology & Data Sciences – Impact on Pharma

      Cambridge, MA

      June 29-30, 2015

      twoXAR CEO, Andrew A. Radin,discusses the impact of big data on drug discovery.

      2015 MIT Sloan Bioinnovations Conference

      Cambridge, MA
      February 26, 2015

      twoXAR CEO, Andrew A. Radin, speaks on Big Data Policy & Personalized Medicine panel with Dr. Khaled El Emam, Dan Meyer, & Nate Russell.

    • Feature Articles

      Will COVID-19 be the straw that breaks AI's back?

      Andrew Radin

      MedCity News

      October 21, 2020

      AI in the Life Sciences 2020

      Global Business Reports
      October 1, 2020

      Xconomy XLS Special Report: The AI, Big Data, and R&D Boom

      Xconomy Special Report

      August 27, 2020

      Code for Cures: Life Sciences Thrives on San Francisco's Software Heritage

      Xconomy
      June 30, 2020

      TXR-311 Shows Promising Preclinical Efficacy and Safety in Hepatocellular Carcinoma​

      Targeted Oncology

      June 26, 2020

      AACR 2020: Positive Preclinical Safety & Efficacy Data for TXR-311 in HCC

      OncoZine

      June 22, 2020

      Ono inks deal with Twoxar as AI-backed drug discovery trend catches fire in Asia

      BioWorld

      April 3, 2019

      AI player twoXAR teams up with 1ST Biotherapeutics on glioblastoma

      FierceBiotech

      January 3, 2019

      twoXAR Lands $10M to Ramp Up AI-Based Drug Discovery Work

      Xconomy

      March 19, 2018

      Bioinformatics startups twoXAR bags $10M in Series A​

      MedCityNews
      March 19, 2018

      A startup that uses software to discover new drugs just raised $10 million

      Business Insider
      March 19, 2018

      Gormley’s Take: Punching Back at Liver Cancer

      Wall Street Journal

      June 2, 2017

      Supercomputers Are Stocking Next Generation Drug Pipelines

      WIRED

      March 29, 2017

      TwoXAR merges artificial intelligence, drug discovery and… clones?

      MedCityNews
      March 19, 2017

      Silicon Valley Computational Drug Startup Takes on Glaucoma

      IEEE Spectrum

      March 13, 2017

      Study reveals drug interactions that may reduce mortality in breast cancer patients

      Stanford Medicine

      December 9, 2016

      Bringing Big Data to Drug Discovery

      MIT Sloan
      September 28, 2016

      Asian Liver Center collaborates with algorithm creator on HCC

      Healio
      September 23, 2016

      Stanford inks computer-driven liver cancer drug discovery pact with twoXAR

      FierceBiotech
      September 12, 2016

      Stanford University, TwoXar Extend Collaboration to Include Liver Cancer

      GenomeWeb
      September 8, 2016

      Pharm Exec's Emerging Pharma Leaders 2016 - The Software Stylists

      Pharmaceutical Executive
      September 1, 2016

      A16z-Backed twoXAR Strikes Software-driven Drug Discovery Pact

      FierceBiotech
      May 27, 2016

      Two Andrews and an Algorithm Aim to Accelerate Drug Discovery

      IEEE Spectrum

      May 6, 2016

      Mission Possible: Software-driven Drug Discovery

      Life Science Leader
      April 1, 2016

      Disrupting Drug Discovery - Article

      MIT Industrial Liaison Program
      February 22, 2016

      A need for speed

      BioCentury
      February 18, 2016

      Two Andrews take Twoxar toward accelerated drug discovery

      BioWorld

      January 25, 2016

      Accelerating Drug Discovery Through Data Analysis

      Drug Discovery & Development
      January 19, 2016

      Bioinformatics Startup TwoXar Building Business Around Computational Drug Discovery Services

      GenomeWeb
      December 1, 2015

      twoXAR Grabs $3.4M for Algorithm-Based Drug Discovery

      Xconomy
      November 18, 2015

      Drug Discovery Startup TwoXar Raises $3.4M

      GenomeWeb

      November 18, 2015

      Improving Health Through Computation

      Scrip Pharma Intelligence
      September 30, 2015

       

      Accelerating Drug Discovery with Machine Learning on Big Medical Data

      datanami
      September 24, 2015

      Entrepreneurs with the same name team up to share a startup as well

      San Francisco Business Times
      August 31, 2015

      How twoXAR Plans to Radicalize the Drug Industry, One Data Set at a Time

      MedTech Boston
      June 1, 2015

      How twoXAR Plans to Radicalize the Drug Industry, One Data Set at a Time

      MedTech Boston
      June 1, 2015

    • Media Mentions

      AI in the Life Sciences: 2020

      Global Business Reports
      September 2020

       

      AI 50: America's Most Promising Artificial Intelligence Companies

      Forbes
      July 3, 2020

       

      Frost & Sullivan Names Top Innovators in Artificial Intelligence for Drug Discovery in the Pharmaceutical Industry

      Frost & Sullivan

      June 9, 2020

      Two leads for the potential treatment of systemic lupus erythematosus demonstrated significant efficacy and excellent tolerability in preclinical studies

      BioWorld

      April 21, 2020

      1ST Biotherapeutics and twoXAR advance three novel glioblastoma treatment candidates

      DDNews

      March 2020

      Preparing Emerging Biotechs For The Best Deals

      Scrip Pharma Intelligence

      February 23, 2018

      AI-powered drug discovery captures pharma interest

      Nature Biotechnology

      July 12, 2017

      Big pharma turns to AI to speed drug discovery, GSK signs deal​

      Reuters

      July 1, 2017

      Andreessen Horowitz Adds General Partners for Bio Fund

      BioCentury
      June 21, 2017

      Hopes in the Machine

      BioCentury

      January 20, 2017

      Chemists pin hopes on deep learning for drug discovery

      Stanford Medicine

      January 23, 2017

      Four Biomed Tech Game Changers From TEDMED

      IEEE Spectrum
      December 6, 2016

      Stopping Breast Cancer with Help from AI

      MIT Technology Review
      October 26, 2016

      The Hopeful Future of Precision Medicine

      TEDMED
      October 21, 2016

      Big data's big challenges in drug discovery

      BioWorld
      July 25, 2016

      Venture capitalist is investing in firms that use computers to improve healthcare

      Los Angeles Times
      January 3, 2016

      Increased Competition, Investments Among Hallmarks of Bioinformatics Market in 2015

      GenomeWeb
      December 31, 2015

      Five Pharma Startups that Made Headlines This Year

      Drug Discovery & Development

      December 7, 2015

      Notable Silicon Valley VC Firm Launches New Biotech Fund

      Drug Discovery & Development
      December 4, 2015

      New Bio Fund Partner Describes A16Z Investment Strategy

      Xconomy
      November 25, 2015

      Andreessen Horowitz places $200M bet on the confluence of IT and biotech

      FierceBiotech
      November 20, 2015

      Venture firm Andreessen Horowitz launches $200 million Bio Fund

      Reuters

      November 18, 2015

      Andreessen Horowitz raises $200M bio fund

      BioCentury
      November 18, 2015

      Andreessen Horowitz Starts Health Care Fund

      New York Times
      November 18, 2015

      Andreessen Horowitz Launches $200M Bio-Computer Fund, Hires Ex-Stanford Prof

      Wall Street Journal
      November 18, 2015

      A top Silicon Valley VC firm is investing $200M in health software startups

      Business Insider

      November 18, 2015

      Andreessen Horowitz launches $200M ‘bio fund’ to bridge gap between tech and biotech

      MedCityNews
      November 18, 2015

       

    • Andrew A. Radin, CEO - TEDMED 2016

    • Webinars, Podcasts, & Videos

      Webinar Series Part 3

      twoXAR Tutorials
      December 2, 2020

      Webinar Series Part 2

      twoXAR Tutorials
      December 2, 2020

      Webinar Series Part 1

      twoXAR Tutorials
      December 2, 2020

      Podcast: Moneyball Medicine

      The Moneyball Medicine Podcast

      September 14, 2020

      Podcast: Moneyball Medicine

      The Moneyball Medicine Podcast

      August 31, 2020

      Video: Oncology Tube Part 1

      Video Oncology Tube Part 2

      Oncology Tube
      August 28, 2020

      Podcast: The AI, Big Data, and R&D Boom

      Xconomy XLS Podcast

      August 26, 2020

      Video: Making AI/ML Tools Scalable Across the Drug Development Lifecycle to Impact Patients

      AI in BioPharma

      July 14, 2020

      Video: twoXAR: Developing Novel Lupus Therapies Amid COVID 19 Research Complications

      Contagion Live
      June 18, 2020

      Video: Drug Bank Fireside Chat

      DrugBank
      May 19, 2020

      Video: MIT Lightning Talk

      MIT ILP Productivity in Biopharma Conference

      December 10, 2019

      Video: The Applications of AI in Drug Discovery

      twoXAR Corporate Seminar

      July 19, 2019

      Podcast: From Validation to Pharma Pipeline—How AI is Finding the Patterns in Data

      Moneyball Medicine Podcast

      October 14, 2018

      Webinar: Practical Application of Artificial Intelligence in Drug Discovery and Development

      ShareVault
      October 12, 2017

      Video: Andrew A. Radin TEDMED Talk

      TEDMED
      December 1, 2016

      Podcast: Move Fast But Don’t Break Things (When It Comes to Computational Biology)

      a16z Podcast

      June 14, 2016

      Podcast: How TwoXAR Is Using Big Data to Accelerate Drug Discovery

      The Bio Report Podcast

      October 27, 2016

      Podcast: What Does "What If" Look Like: Andrew Radin/twoXAR - TEDMED

      TBWA\WorldHealth
      January 23, 2017

    • Publications & Posters

      Poster: Preclinical identification and development of small molecule drug discovery leads with novel MOAs for non-alcoholic steatohepatitis (NASH)

      Isaac Hakim, Sana Mujahid, Aaron C. Daugherty, Anjali Pandey, Timothy S. Heuer

       

      Download Poster (PDF)

       

      Poster: Computational discovery and preclinical validation of therapeutic leads with novel MOAs for hepatocellular carcinoma and pancreatic ductal adenocarcinoma

      Isaac Hakim, Mei-Sze Chua, Wei Wei, Li Ma, Samuel So, Elizabeth Noblin, Sana Mujahid, Aaron C. Daugherty, and Timothy S. Heuer

       

      Download Abstract

      Download Poster (PDF)

      Download Audio

      Abstract: Computational discovery and preclinical validation of therapeutic leads with novel MOAs for systemic lupus erythematosus (SLE)​

      Isaac Hakim, Sana Mujahid, Aaron C Daugherty and Timothy S Heuer

      Poster: Computational discovery and preclinical validation of therapeutic leads with novel MOAs for systemic lupus erythematosus (SLE)​

      Isaac Hakim, Sana Mujahid, Aaron C Daugherty and Timothy S Heuer

       

      Download Abstract (PDF)

      Download Poster (PDF)

      Synergistic drug combinations from electronic health records and gene expression

      Yen S Low, Aaron C Daugherty, Elizabeth A Schroeder, William Chen, Tina Seto, Susan Weber, Michael Lim, Trevor Hastie, Maya Mathur, Manisha Desai, Carl Farrington, Andrew A Radin, Marina Sirota, Pragati Kenkare, Caroline A Thompson, Peter P Yu, Scarlett L Gomez, George W Sledge Jr, Allison W Kurian, Nigam H Shah. Journal of the American Medical Informatics Association. EPub: December 9, 2016​

      Rapid Identification and Validation of Novel Rheumatoid Arthritis Drug Treatments using an Integrative Bioinformatics Platform​

      Aaron C Daugherty, Carl Farrington, Isaac Hakin, Sana Mujahid, Elizabeth S Noblin, Andrew M Radin, Mei-Sze Chua, Mark Rabe, Guy Fernald, Daniel Ford, Marina Sirota, Laura Schaevitz, Andrew A Radin. bioRxiv 243998; doi: https://doi.org/10.1101/243998

      Poster: An Integrative Bioinformatics Approach Identifies In Vivo Validated Drug Candidates with Novel Mechanisms of Action in Rheumatoid Arthritis

      Aaron C Daugherty1, Carl Farrington1, Isaac Hakim1, Elizabeth S Noblin1, Andrew M Radin1, Mei-Sze Chua2, Mark Rabe3, Guy Fernald3, Daniel Ford3, Marina Sirota4, Laura Schaevitz3, Andrew A Radin1

      1twoXAR, 2Stanford University School of Medicine, 3Vium, 4UCSF

       

      Download Poster (PDF)

      Download Supplementary Material (PDF)

    © 2021 twoXAR, Incorporated | All Rights Reserved

      Home
      Pipeline
      News
      Contact
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More